Technical Specifications

Specification	Details
Product Name	KLOW Peptide
Total Blend Amount	80 mg
GHK-Cu	50 mg
BPC-157	10 mg
TB-500	10 mg
KPV	10 mg
Composition	Four-Peptide Research Blend
Form	Lyophilized Peptide Blend
Purity	≥98% per constituent, subject to CoA
Classification	Multi-Peptide Research Blend
Intended Use	Laboratory Research Only

---

Product Overview

KLOW Peptide is a multi-peptide research blend combining GHK-Cu, BPC-157, TB-500, and KPV into a single lyophilized preparation.

The commonly documented formulation contains 80 mg total peptide material, consisting of 50 mg GHK-Cu, 10 mg BPC-157, 10 mg TB-500, and 10 mg KPV.

Each component has been investigated independently in experimental research involving different biological pathways. GHK-Cu has been studied in relation to extracellular-matrix remodeling and collagen-related processes; BPC-157 in experimental tissue-repair and vascular research; TB-500 in cell migration and tissue-repair research; and KPV in inflammatory-signaling studies.

KLOW is therefore best understood as a research blend of four distinct molecules, rather than a single chemical entity.

---

Mechanism of Action

Research on the individual components has investigated several biological mechanisms:

GHK-Cu Research

GHK-Cu is a copper-binding peptide investigated in research involving extracellular-matrix remodeling, collagen-related processes, cellular signaling, and skin biology.

BPC-157 Research

BPC-157 has been investigated primarily in preclinical models involving tissue repair, vascular signaling, cellular protection, and angiogenic pathways.

TB-500 Research

TB-500 is a synthetic peptide associated with thymosin beta-4 research and has been investigated in relation to actin-associated cellular processes, cell migration, angiogenesis, and tissue remodeling.

KPV Research

KPV is a tripeptide fragment related to α-MSH that has been investigated in experimental models involving inflammatory signaling and epithelial biology.

Combined Research Concept

The rationale behind KLOW is that these four components may provide complementary research pathways involving tissue remodeling, cellular migration, inflammatory signaling, and extracellular-matrix processes.

However, this combined mechanism remains a research hypothesis. The available evidence primarily concerns the individual peptides rather than KLOW as a complete formulation.

---

Research Applications

KLOW Peptide may be investigated in laboratory settings involving:

• Tissue-repair research
• Extracellular-matrix studies
• Cellular migration research
• Angiogenesis research
• Inflammatory signaling studies
• Collagen and connective-tissue research
• Skin biology research
• Cellular signaling research
• Experimental regenerative biology
• Synthetic peptide research

---

Handling & Storage

• Store the lyophilized peptide blend according to the manufacturer’s recommended conditions.
• Protect from excessive heat, moisture, and direct sunlight.
• Keep the product sealed in its original packaging until required for laboratory research.
• Follow the batch-specific Certificate of Analysis for exact storage requirements.
• Minimize unnecessary exposure to temperature fluctuations.
• If the material is prepared for laboratory experiments, follow validated laboratory procedures appropriate for the individual constituents.

---

Product Features

✓ Research Grade Peptide Blend

✓ 80mg Total Blend

✓ GHK-Cu 50mg

✓ BPC-157 10mg

✓ TB-500 10mg

✓ KPV 10mg

✓ Lyophilized for Stability

✓ Carefully Packaged

✓ Laboratory Research Use Only

---

Important Notice

This product is intended exclusively for laboratory research purposes.

It is not intended for human or veterinary use, administration, injection, consumption, diagnosis, treatment, cure, or prevention of any disease.

KLOW Peptide is an experimental multi-peptide research formulation. Research findings relating to individual components should not be interpreted as evidence that the combined KLOW formulation produces the same effects or demonstrates synergistic activity.

The composition, constituent amounts, purity, and analytical specifications should always be verified against the applicable batch Certificate of Analysis (CoA).

By purchasing this product, the purchaser acknowledges that it will be handled only by qualified professionals in appropriate laboratory environments and used in accordance with applicable laws, regulations, and institutional protocols.

---

Frequently Asked Questions

What is KLOW Peptide?

KLOW Peptide is a four-component research blend consisting of GHK-Cu, BPC-157, TB-500, and KPV.

What does KLOW Peptide contain?

The commonly documented 80mg formulation contains:

• GHK-Cu: 50mg
• BPC-157: 10mg
• TB-500: 10mg
• KPV: 10mg

The exact formulation should be confirmed against the product’s batch-specific CoA.

Is KLOW Peptide one peptide?

No. KLOW is a four-peptide blend, meaning it does not have a single molecular formula, molecular weight, or amino-acid sequence.

What is KLOW researched for?

The individual components are investigated in areas including tissue-repair research, extracellular-matrix remodeling, cellular migration, inflammatory signaling, angiogenesis, and skin biology.

Is there research on KLOW as a complete blend?

Research exists on the individual components, but the available literature does not establish the efficacy or synergy of the four components when combined as KLOW. Claims about the blend as a whole should therefore be treated as experimental extrapolations.

Is KLOW Peptide intended for human use?

No. This product is supplied strictly for laboratory research purposes and is not intended for human or veterinary use.

How should KLOW Peptide be stored?

The lyophilized blend should be protected from heat, moisture, and direct sunlight and stored according to the manufacturer’s recommended conditions. Always refer to the applicable batch CoA for exact storage requirements.